Outset Medical Inc.

The US Food and Drug Administration has issued seven high-risk class I medical device recalls over the last week, with the safety announcements targeting industry sectors including dialysis, diagnosti

Biopharma Financing Biopharma financings during the fourth quarter of 2022 totaled $17.5bn from 282 deals; of those, 53 financings met or exceeded the $100m mark. Overall, follow on public offerings (

At-home dialysis pioneer Outset Medical Inc. has been coming off a successful year, posting $102.6m in full-year 2021 revenues, an increase of 105% year-over-year, and tripling its install base for

Outset Medical Inc. has received the first-ever approval from the US Centers for Medicare & Medicaid Services (CMS) for a Transitional Add-on Payment Adjustment for New and Innovative Equipment and S